Case Report
Accepted on 26 Feb 2026
Adefovir Dipivoxil-Induced Hypophosphatemic Osteomalacia and Osteoporosis: A Case Report and Literature Review
in Bone Research
Frontiers in Endocrinology
8 articles related to "Adefovir Dipivoxil"
Articles
Systematic Review
Published on 16 Jan 2023
Efficacy of nucleos(t)ide analogues(NAs) in preventing virus reactivation in oncology patients with HBV infection after chemotherapy or surgery: A network meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1050714
- 3,073 views
- 2 citations
Brief Research Report
Published on 01 Aug 2025
Adefovir dipivoxil-associated Fanconi syndrome combined with peripheral neuropathy: a case report and literature review
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1585126
- 1,416 views
Original Research
Published on 27 Sep 2021
Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition
in Interventions in Aging
Frontiers in Aging
doi 10.3389/fragi.2021.738512
- 5,848 views
- 14 citations
Original Research
Published on 28 Apr 2021
Follow-Up of Adefovir Dipivoxil Induced Osteomalacia: Clinical Characteristics and Genetic Predictors
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2021.636352
- 3,160 views
- 2 citations
Original Research
Published on 08 Jan 2021
Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation
in Autoimmune and Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2020.616570
- 5,886 views
- 9 citations
Original Research
Published on 19 Aug 2022
Drug-induced Fanconi syndrome in patients with kidney allograft transplantation
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2022.979983
- 7,984 views
- 8 citations
Original Research
Published on 03 Jan 2022
Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System
in Obstetric and Pediatric Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.772768
- 7,439 views
- 23 citations